Effect of Nebulized Bronchodilators on Heart Rate

PHASE4CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
COPDSepsisShock
Interventions
DRUG

Levalbuterol

inhaled Levalbuterol 0.625 mg inhaled Levalbuterol 2.5 mg

DRUG

Albuterol

Nebulized albuterol 2.5mg

Trial Locations (1)

48439

Genesys Regional Medical Center, Grand Blanc

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ascension Health

INDUSTRY

lead

Fahim Khorfan, MD

INDUSTRY